Humans with mutations in HGD, which encodes an intermediate enzyme in the Phe/Tyr catabolic pathway, develop Alkaptonuria, or black bone disease, due to accumulation and pathological aggregation of homogentisic acid16. The gene discussed is HGD; the disease is alkaptonuria.